Evidence map›Paper›PMID 38189403›Full record

ArticleNan fang yi ke da xue xue bao = Journal of Southern Medical University2023

[Rapamycin enhances inhibitory effect of RSL3 on proliferation, invasion and migration of testicular cancer I-10 cells

B Li, Y Wang, F Hou, J DU, X Tong

Open access · greenAbstract readEnglish Abstract
In one paragraph

Article in Nan fang yi ke da xue xue bao = Journal of Southern Medical University, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 0 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

B LiSchool of Pharmacy, Bengbu Medical College, Anhui Provincial Engineering Research Center for Biochemical Pharmaceuticals, Bengbu 233030, China.
Y WangSchool of Pharmacy, Bengbu Medical College, Anhui Provincial Engineering Research Center for Biochemical Pharmaceuticals, Bengbu 233030, China.
F HouSchool of Pharmacy, Bengbu Medical College, Anhui Provincial Engineering Research Center for Biochemical Pharmaceuticals, Bengbu 233030, China.
J DUSchool of Pharmacy, Bengbu Medical College, Anhui Provincial Engineering Research Center for Biochemical Pharmaceuticals, Bengbu 233030, China.
X TongSchool of Pharmacy, Bengbu Medical College, Anhui Provincial Engineering Research Center for Biochemical Pharmaceuticals, Bengbu 233030, China.
Bengbu Medical College · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo investigate the effect of rapamycin for enhancing the inhibitory effect of RSL3 on proliferation, invasion and migration of testicular cancer I-10 cells

methodsI-10 cells treated with 0-16 μmol/L RSL3 (Type Ⅱ) either alone or in combination with 16 μmol/L rapamycin (RAPA) were examined for changes in proliferation using MTT assay and colonyforming assay, and the changes in cell migration and invasion abilities were detected with wounding-healing assay and Transwell assay. The changes in the levels of lipid reactive oxygen species in the treated cells were detected using flow cytometry. GSH and MDA contents in the cells were detected using commercial detection kits, and GPX4 protein expression level was determined with Western blotting.

resultsThe cytotoxic effect of RSL3 increased dose-dependently in I-10 cells, and the combined treatment with rapamycin further enhanced its cytotoxicity. Treatment of I-10 cells with RSL3 alone significantly decreased cell colony numbers (

conclusionRapamycin enhances the inhibitory effect of RSL3 on proliferation, invasion and migration of I-10 cells by enhancing RSL3-mediated cell ferroptosis.

Indexed as

Testicular NeoplasmsCell ProliferationHumansLipidsMaleNeoplasms, Germ Cell and EmbryonalReactive Oxygen SpeciesSirolimusLipidsReactive Oxygen SpeciesSirolimusferroptosisinvasionmigrationproliferationrapamycinRAS-selective lethal 3testicular cancer

Identifiers

PMID38189403
PMCPMC10774114
OpenAlexW4390744084

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.